Results 151 to 160 of about 1,362 (278)

Development and validation of the Essen Melanoma Quality of Life Inventory (EMQoLI)

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives New treatments for melanoma, such as targeted therapy and immunotherapy, present unique adverse events compared to traditional treatments like surgery and chemotherapy. Existing health‐related quality of life (HRQoL) measures often fail to address these new treatment effects and focus primarily on chemotherapy and ...
Venja Musche   +10 more
wiley   +1 more source

Spinoza on Humans as Social Animals

open access: yesEuropean Journal of Philosophy, EarlyView.
Abstract Spinoza repeatedly suggests that humans are set apart from other animals by their rational and moral abilities. Yet he disparages the traditional definition of the human as a ‘rational animal’ and several of his other views suggest that these abilities are not sufficient by themselves to characterize human nature.
Ruben Noorloos
wiley   +1 more source

Spinal motor neuron pools may be partly driven by impulsive common inputs. [PDF]

open access: yesJ Physiol
Yanguas Mayo J   +5 more
europepmc   +2 more sources

Generalized β-Hyers-Ulam-Rassias Stability of Impulsive Difference Equations. [PDF]

open access: yesComput Intell Neurosci, 2022
Almalki Y   +5 more
europepmc   +1 more source

The compounding effects of accumulated perceived employer exploitation when tough business decisions must be made

open access: yesEuropean Management Review, EarlyView.
Abstract We examine how a single exploitative employer decision event, conceptualized as a shock, interacts with employees' accumulated perceived employer exploitation to amplify feelings of violation and influence adverse employee reactions. This interaction effect, and its boundary conditions, constitutes the primary theoretical contribution of the ...
Dorothea Roumpi   +3 more
wiley   +1 more source

Weight loss with atogepant in the long‐term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open‐label, 156‐week extension study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess weight loss with atogepant 60 mg once daily during long‐term treatment of chronic migraine (CM) and episodic migraine (EM) among participants previously failed by two to four classes of conventional oral preventive medications.
Dale S. Bond   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy